검색어: luteal phase (영어 - 하우사어)

five vaccine candidates were in phase i safety studies in april.
‘yan maganin rigakafi su biyar na cikin mataki i na karatun lafiya cikin afrilu.

major platform targets advanced into phase i safety studies include:
zauruka dayawa sun danawa sihag cigaban shashi na i akan karatun kariya kamar;

phase i trials, usually in healthy volunteers, determine safety and dosing.
fuska i na gwaji, yawanci lokaci a cikin masu sa kai da ke aikin lafiya, da allura.

the partners further announced plans for preclinical testing and a phase i clinical trial by july 2020.
abokan haɗin gwiwar sun kara ba da sanarwar shirye-shiryen gwajin fari da mataki i na gwajin asibiti a watan yuli 2020.

it is undergoing a phase 2 non randomised test at the national level in italy after showing positive results in people with severe disease.
yana cikin gwajin sashe na 2 gwaji wanda ba daga ko ina ba ne a kasar italy bayan nuna sakamakon mutane masu tsananin ciwo.

others in early-stage phase ii trials or numerous treatment candidates in phase i trials, are also excluded.
wasu kuma a farkon-dakali gwajin matakan ii yawan maganin gwaji a mataki i, an cire su.

as a potential combination therapy, they are used together in two phase iii arms of the 2020 global solidarity project on covid-19.
a matsayin haduwar jinya, ana amfani dasu tare a matakai iii na ayyukan shekarar 2020 na ayyukan hadin kan duniya akan cutar covid-19.

phase iii trials are large, pivotal trials to determine safety and efficacy in sufficiently large numbers of people with the covid-19 infection.
gwajin zagaye na iii manya ne, gwajin gabobi don tabbatar da kariya da ma gudananrwa ga mafi yawan mutane masu dake da covid-19.

however, the transmission of sars-cov was considered to occur when the patients are severely ill, while most transmission did not happen at the early phase.
duk da haka, an dauke watsar da sars-cov na faru lokacin da marasa lafiya ke fama da rashin lafiya, yayin da yawancin watsawa basu faru ba a farkon lokaci.

as of early april 2020, 103 candidate therapeutics were in preclinical or a stage of phase i-iv development, with trial results for 29 drug candidates expected during april.
tun daga farkon afrilu 2020, magwajin cututtuka guda 103 sun kasance cikin farin gwajin habbakawar mataki i-iv, da wancan sakamakon maganin gwaji guda 29 wanda ake bukata watan afrilu.

drug candidates in phase i-ii trials have a low rate of success (under 12%) to pass through all trial phases to gain eventual approval.
masu gwajin magani shashe na i-ii ba su da nasar kar kashi 12% bisa dari sai sun bi dukkan shahse kafi sammun yadda ta gaske.

phase iii clinical trials are being conducted in the us, china and italy.chloroquine, previously used to treat malaria, was studied in china in february 2020, with preliminary results.
ana gudanar da gwaji na asibiti na phrase iii a amurka, china da italiya. chloroquine a da can ana amfani da shi don maganin zazzabin cizon sauro, an yi nazarin karatun a cikin china a shekarar 2020 tate da saka mako na farko.

adaptive designs within ongoing phase ii-iii clinical trials on candidate therapeutics may shorten trial durations and use fewer subjects, possibly expediting decisions for early termination or success, and coordinating design changes for a specific trial across its international locations.
tsarin daidaitawa tsakanin gwajin asibiti wanda ake kai yi na matakai ii-iii akan jinyar magwajin na iya rage lokacin gwaji da kuma amfani da karamar take, da yiwuwar yanke hukuncin ko ci nasara, da daidaita canje-canjen ƙira don takamaiman gwaji a duk faɗin ƙasashen duniya.

" control of public movement was applied in many cities, and it has been estimated that about 760 million people (more than half the population) faced some form of outdoor restriction.after the outbreak entered its global phase in march, chinese authorities took strict measures to prevent the virus from ""importing"" from other countries. "
"an yi amfani da ikon motsi a cikin birane da yawa, kuma an kiyasta cewa kimanin mutane miliyan 760 (sama da rabin yawan jama'a) sun fuskanci wani nau'in dokar hana fita daga waje. bayan barkewar cutar ta shiga matsayinta na duniya a watan maris, hukumomin kasar sin sun dauki tsauraran matakan. hana cutar daga ""shigo da"" daga wasu ƙasashe."